证券记录 · 已归档季度
GH
Guardant Health, Inc. · Healthcare · Medical - Diagnostics & Research
17被追踪持有人
-1Δ持有人
25.07M持有股份
$1.07B报告持仓市值
+0新建仓位
−1清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q1 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 72.94K | $12.83M | n/a | n/a |
| Q2 2026 | 139 | +11 | 93.66M | $13.96B | +17 | −5 |
| Q1 2026 | 130 | -8 | 97.95M | $8.77B | +5 | −14 |
| Q4 2025 | 137 | +1 | 99.79M | $9.86B | +2 | n/a |
| Q3 2025 | 22 | +1 | 50.89M | $3.18B | +2 | −2 |
| Q2 2025 | 19 | -1 | 51.15M | $2.66B | n/a | −1 |
| Q1 2025 | 17 | -1 | 25.07M | $1.07B | n/a | −1 |
| Q4 2024 | 18 | +2 | 25.10M | $766.76M | +2 | n/a |
| Q3 2024 | 15 | +1 | 25.31M | $580.70M | +2 | −1 |
| Q2 2024 | 14 | n/a | 24.13M | $697.01M | n/a | n/a |
持有人 · Q1 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 5.06M | -7.1% | $215.60M | 0.2% | ▼ Trim | 4 | SEC ↗ ×4 |
| 2 | Citadel Advisors ✦ | 3.60M | +142.7% | $153.23M | 0.2% | ▲ Add | 4 | SEC ↗ ×2 |
| 3 | Geode Capital Management ✦ (被动) | 2.91M | +3.0% | $123.89M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 4 | State Street Global Advisors ✦ (被动) | 2.80M | -1.7% | $119.28M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 5 | Wellington Management ✦ | 1.99M | -58.9% | $84.98M | 0.0% | ▼ Trim | 4 | SEC ↗ ×4 |
| 6 | Two Sigma Investments ✦ | 1.83M | -3.4% | $77.78M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 7 | ARK Investment Management ✦ | 1.41M | -2.1% | $60.03M | 0.6% | ▼ Trim | 4 | SEC ↗ |
| 8 | Norges Bank ✦ (被动) | 1.21M | +1.7% | $51.66M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Millennium Management ✦ | 1.10M | -10.6% | $46.72M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | Adage Capital Partners ✦ | 846.75K | +202.6% | $36.07M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 776.57K | -11.1% | $33.08M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 629.51K | +553.0% | $26.82M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 13 | Renaissance Technologies ✦ | 616.50K | +22.5% | $26.26M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Marshall Wace ✦ | 176.53K | +450.2% | $7.52M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 15 | AQR Capital Management ✦ | 71.53K | +56.5% | $3.01M | 0.0% | ▲ Add | 3 | SEC ↗ ×5 |
| 16 | PRIMECAP Management ✦ | 43.69K | 0.0% | $1.86M | 0.0% | Held | 4 | SEC ↗ |
| 17 | Bridgewater Associates ✦ | 5.07K | -59.6% | $215,982 | 0.0% | ▼ Trim | 4 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Gotham Asset Management | $238,932 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 481 持有人, 137.05M 股份, $11.53B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Oct 16
Tariq Musa
Director · 116 股 · $19,242
Oct 14
Azar Alex M II
Director · 69 股 · $11,032
Sep 16
Krognes Steve E.
Director · 1.10K 股 · $192,432
Sep 16
Azar Alex M II
Director · 826 股 · $144,550
Sep 16
Krognes Steve E.
Director · 3.30K 股 · $578,888
Sep 16
Krognes Steve E.
Director · 1.30K 股 · $229,236
Sep 16
Krognes Steve E.
Director · 971 股 · $172,330
Sep 16
Tariq Musa
Director · 116 股 · $20,300
Sep 15
Chudova Darya
Officer · 7.74K 股 · $1.38M
Sep 11
Kalia Kumud
Officer · 4.00K 股 · $632,193
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 14
SC 13G/A: PRICE T ROWE ASSOCIATES INC /MD/
Jul 28
SC 13G/A: BlackRock, Inc.
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q1 2025 ·
方法论 ·
通过API获取此数据